Pigment epithelium-derived factor attenuates myocardial fibrosis via inhibiting Endothelial-to-Mesenchymal Transition in rats with acute myocardial infarction

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Zhang, Hao ^a   Hui, Hongliang ^a   Li, Zhimin ^a   Pan, Jiajun ^a   Jiang, Xia ^a   Wei, Tengteng ^a   Cui, Huazhu ^a   Li, Lei ^a   Yuan, Xulong ^a   Sun, Teng ^a   Liu, Zhiwei ^a   Zhang, Zhongming ^a   Dong, Hongyan ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ACUTE DISEASE; ANIMAL; APOPTOSIS; CARDIAC MUSCLE; CARDIOMYOPATHY; CELL CULTURE; CELL MOTION; COMPLICATION; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; GENETICS; HEART INFARCTION; MALE; METABOLISM; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; ANIMALS; APOPTOSIS; CARDIOMYOPATHIES; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EPITHELIAL-MESENCHYMAL TRANSITION; EYE PROTEINS; FIBROSIS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NERVE GROWTH FACTORS; RATS; RATS, SPRAGUE-DAWLEY; SERPINS; SIGNAL TRANSDUCTION;

EID: 85011878153     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41932     Document Type: Article

References (37)

1. Coelho-Filho, O. R. et al. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone. J Am Heart Assoc 3, e000790-e000790 (2014).
2. Widyantoro, B. et al. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 121, 2407-2418 (2010).
3. Krenning, G., Zeisberg, E. M. & Kalluri, R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 225, 631-637 (2010).
4. Rychli, K. et al. The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts. J Cell Mol Med 14, 198-205 (2010).
5. Gao, X. et al. PEDF and PEDF-derived peptide 44mer protect cardiomyocytes against hypoxia-induced apoptosis and necroptosis via anti-oxidative effect. Sci Rep 4, 5637 (2014).
6. Zhang, H. et al. PEDF improves cardiac function in rats with acute myocardial infarction via inhibiting vascular permeability and cardiomyocyte apoptosis. Int J Mol Sci 16, 5618-5634 (2015).
7. Ueda, S., Yamagishi, S., Matsui, T., Jinnouchi, Y. & Imaizumi, T. Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction. Am J Pathol 178, 591-598 (2011).
8. Maric, C., Ryan, G. B. & Alcorn, D. Embryonic and postnatal development of the rat renal interstitium. Anat Embryol (Berl) 195, 503-514 (1997).
9. Lang, H. & Fekete, D. M. Lineage analysis in the chicken inner ear shows differences in clonal dispersion for epithelial, neuronal, and mesenchymal cells. Dev Biol 234, 120-137 (2001).
10. Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13, 952-961 (2007).
11. Frid, M. G., Kale, V. A. & Stenmark, K. R. Mature vascular endothelium can give rise to smooth muscle cells via endothelialmesenchymal transdifferentiation: in vitro analysis. Circ Res 90, 1189-1196 (2002).
12. Laser, A. et al. Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling. Arterioscler Thromb Vasc Biol 34, 377-385 (2014).
13. Ljungqvist, A. & Unge, G. The proliferative activity of the myocardial tissue in various forms of experimental cardiac hypertrophy. Acta Pathol Microbiol Scand A 81, 233-240 (1973).
14. Xu, X. et al. Endocardial fibroelastosis is caused by aberrant endothelial to mesenchymal transition. Circ Res 116, 857-866 (2015).
15. Bujak, M. & Frangogiannis, N. G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74, 184-195 (2007).
16. Zhao, W., Zhao, D., Yan, R. & Sun, Y. Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase. Cardiovasc Pathol 18, 156-166 (2009).
17. Zhou, S. X., Zhou, Y., Zhang, Y. L., Lei, J. & Wang, J. F. Antioxidant probucol attenuates myocardial oxidative stress and collagen expressions in post-myocardial infarction rats. J Cardiovasc Pharm 54, 154-162 (2009).
18. Angers, S. & Moon, R. T. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 10, 468-477 (2009).
19. White, B. D., Nguyen, N. K. & Moon, R. T. Wnt signaling: it gets more humorous with age. Curr Biol 17, R923-925 (2007).
20. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
21. Schmalhofer, O., Brabletz, S. & Brabletz, T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28, 151-166 (2009).
22. Polette, M. et al. Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs 185, 61-65 (2007).
23. Masszi, A. et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 165, 1955-1967 (2004).
24. Zheng, G. et al. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 175, 580-591 (2009).
25. Liebner, S. et al. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol 166, 359-367 (2004).
26. Gogiraju, R. et al. Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice. J Am Heart Assoc 4, e001770-e001770 (2015).
27. Ranchoux, B. et al. Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation 131, 1006-1018 (2015).
28. Wynn, T. A. Cellular and molecular mechanisms of fibrosis. J Pathol 214, 199-210 (2008).
29. Tian, X. et al. Association of beta-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-beta1. J Cell Sci 126, 67-76 (2013).
30. Labbe, E., Letamendia, A. & Attisano, L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci USA 97, 8358-8363 (2000).
31. Nishita, M. et al. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403, 781-785 (2000).
32. Tian, Y. C. & Phillips, A. O. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and betacatenin during transforming growth factor-beta1-mediated adherens junction disassembly. Am J Pathol 160, 1619-1628 (2002).
33. Park, K. et al. Identification of a novel inhibitor of the canonical Wnt pathway. Mol Cell Biol 31, 3038-3051 (2011).
34. Tward, A. D. et al. Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc Natl Acad Sci USA 104, 14771-14776 (2007).
35. Orenstein, T. L. et al. Favorable left ventricular remodeling following large myocardial infarction by exercise training. Effect on ventricular morphology and gene expression. J Clin Invest 96, 858-866 (1995).
36. Ahmet, I., Lakatta, E. G. & Talan, M. I. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy. Heart Fail Rev 10, 289-296 (2005).
37. Hao, S. et al. Targeted inhibition of beta-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22, 1642-1653 (2011).